Clinical Trials Logo
  1. Home
  2. Renal Artery Obstruction
  3. NCT01344460

Gadobutrol Enhanced MRA of the Renal Arteries — GRAMS  

Renal Artery Obstruction Clinical Trial

Official title:
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Gadobutrol-enhanced Magnetic Resonance Angiography (MRA) After a Single Injection of 0.1 mmol/kg of Gadobutrol in Subjects With Known or Suspected Renal Artery Disease

Clinical Trial Summary

Subjects referred for a routine CTA (computed tomography angiography) or MRA (magnetic resonance angiography) will be invited to participate in the study and subjects will be involved in the study for between 2 and 12 days. Two to three visits to the study doctor will be required.

This study will compare the diagnostic results of Gadobutrol enhanced MRA images with MRA images taken without contrast agent using images from a CTA as the standard of reference, which may have been performed up to 60 days prior to enrolment. If a CTA has not been performed in this prior time period, a CTA is required for the study.

MRA and CTA images will be collected for an independent review (blinded read).

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01344460
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 3
Start date May 2011
Completion date July 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00868972 - Renal Stenting With Distal Atheroembolic Protection Phase 2/Phase 3
Completed NCT00150943 - Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis Phase 3
Completed NCT03521700 - Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement Phase 2/Phase 3
Terminated NCT00180544 - Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease Phase 3
Recruiting NCT02770066 - A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
Terminated NCT01755858 - Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery Phase 1/Phase 2
Completed NCT00027469 - MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery Phase 1
Completed NCT00490841 - The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis N/A
Recruiting NCT03530748 - On-table Renal Perfusion Evaluation Renal Artery Stenosis or Obstruction
Not yet recruiting NCT03080519 - Endovascular Therapy for Renal Artery Stenosis in China N/A
Completed NCT00081731 - Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions Phase 3